Walleye Capital’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $382K | Buy |
+34,659
| New | +$382K | ﹤0.01% | 1170 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2686 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 2599 |
|
|
2022
Q3 | – | Sell |
-82,758
| Closed | -$750K | – | 2727 |
|
|
2022
Q2 | $750K | Buy |
82,758
+44,958
| +119% | +$407K | 0.02% | 780 |
|
|
2022
Q1 | $361K | Buy |
+37,800
| New | +$361K | 0.01% | 1159 |
|
|
2021
Q3 | – | Sell |
-16,688
| Closed | -$242 | – | 1783 |
|
|
2021
Q2 | $242 | Buy |
+16,688
| New | +$242 | 0.01% | 993 |
|